Visual Outcomes After Presbyopia Correcting Intraocular Lens In Patients With Age Macular Degeneration
Published 2024 - 42nd Congress of the ESCRS
Reference: FP17.01 | Type: Free paper | DOI: 10.82333/6mkd-ca34
Authors: Belen Elvira-Giner* 1 , Juan Carlos Elvira-Cruañes 1 , Patricia Devesa-Torregrosa 1 , Paz Orts-Vila 1 , Pedro Tañá-Rivero 1
1Oftalvist,Alicante,Spain
Purpose
The objective of the present preliminary study is to evaluate the visual outcomes in a series of cataract eyes with age macular degeneration (AMD) implanted with the presbyopia correcting AcrySof IQ Vivity IOL. This study was approved by the Ethics Committee of the Hospital Clínico San Carlos (Madrid, Spain). These are preliminary results of a larger study with 25 subjects targeted
Setting
Methods
Inclusion Criteria considered age-related cataract surgery patients, based on the fundus examination, macular OCT or autofluorescence, show a mild pathology that does not recommend a trifocal IOL in one or both eyes, drupes (drupelets or small drusen <63 microns) in one or both eyes, early AMD with medium drusen of 63-125 microns without AMD-related pigment changes, and pigment epithelium alterations without geographic component, mild alteration in macular OCT study, with partial loss of the ellipsoid line. Exclusion criteria considered advanced or intermediate AMD, other ocular co-morbidities or disease and previous ocular surgeries. All surgeries will be done using the same surgical technique, equipment and postoperative treatment.
Results
Monocular uncorrected and corrected distance visual acuity (UDVA and CDVA), uncorrected and corrected distance monocular intermediate (66 cm, UIVA and DCIVA) and near (40 cm, UNVA and DCNVA), refraction and monocular defocus curves were measured in 10 patients at 6 months. All patients were implanted with the EDOF AcrySof IQ Vivity IOL bilaterally but only one eye per patient was included in the statistical analysis. Mean spherical equivalent was -0.33±0.50D, mean UDVA, CDVA, UIVA, DCIVA, UNVA and DCNVA were 0.10±0.09, 0.03±0.06, 0.20±0.15, 0.22±0.13, 0.31±0.19, and 0.33±0.19 logMAR, respectively. In relation to the defocus curve, at the visual acuity threshold of 0.20 logMAR (20/32), monocular depth-of-focus reported was about 1.75D.
Conclusions
The use of the presbyopia correcting AcrySof IQ Vivity IOL in cataract patients with AMD provides accurate good visual acuity outcomes.